1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
615448633087249A9852569670059B4C5
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/maximizing-blockbuster-potential-through-marketing-excellence-an-executive-summary?opendocument
18
19opendocument
2035.172.195.49
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Marketing Management Marketing Strategy

Maximizing Blockbuster Potential through Marketing Excellence -- An Executive Summary

DB Image

ID: 3610


Features:


Words: 2,523


Published: Pre-2014


Delivery Format: Online


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Project Background
Best Practices, LLC has performed an industry-wide benchmark study on
multi-phased marketing support for new products across an elite group of high
performing pharmaceutical companies. The study produced numerous findings that
will enable pharmaceutical executives to understand the winning strategies,
practices, team structures and investment patterns that distinguish successful
new product development and marketing planning. Moreover, the project findings
will enable companies to move knowledgeably toward the objective of developing
its own world-class marketing support capabilities.

This study’s key goals and objectives were as follows:
Determine the multi-year marketing support investment and expense
patterns for high-potential products;
Profile the structure of marketing support organizations at leading
pharmaceutical companies;
Identify best management practices employed during new product
development and marketing planning; and
Harvest the key Lessons Learned in planning and coordinating
successful product launches.

The leading practices, managerial insights and benchmark metrics in this report
are drawn from in-depth interviews (1-2 hours per interview) with more than 24
executives at 12 leading pharmaceutical companies. Additionally,
pharmaceutical marketing support information was gathered from various other
sources, including Best Practices, LLC’s own proprietary databases, other
public and private databases, literature reviews, and on-line data research ...

Industries Profiled:
Pharmaceutical; Biotech; Health Care


Companies Profiled:
Amgen; Boehringer-Ingelheim; Eli Lilly; GlaxoSmithKline; Novartis; Pharmacia; Hoechst Marion Roussel; Parke-Davis; Pfizer; Merck

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.